InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Jones David Scott, Vice-Président Senior et Directeur Commercial. Officer active across 1 company, notably EyePoint Pharmaceuticals, Inc.. In total, 9 reports have been recorded. Activity tracked since 9 February 2022. The latest transaction was filed on 9 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
David Scott Jones serves as Senior Vice President and Chief Commercial Officer at EyePoint Pharmaceuticals, Inc. He is responsible for commercial strategy and managing customer relationships. His role includes implementing strategies to increase sales and market share for the company.